Journal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
Volume 7, Issue 1, Pages 59-61Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrgastro.2009.197
Keywords
-
Categories
Ask authors/readers for more resources
The emergence of novel pharmacologic therapies for hepatic fibrosis holds promise for the management of this condition. Furthermore, novel, biological indices-in addition to liver biopsy-may improve our ability to assess the unique pharmacological effects generated by these agents. This article will attempt to highlight the potential for emerging biomarkers to serve as end points in clinical studies that target salient features of hepatic fibrogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available